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A B S T R A C T
The Eu3+ and Sr2+ ions co-doped hydroxyapatite nanopowders (Ca10(PO4)6(OH)2) were synthesized via a
precipitation method and post heat-treated at 500 °C. The concentration of Eu3+ ions was established in the
range of 0.5–5mol% to investigate the site occupancy preference. The concentration of Sr2+ ions was set at
5 mol%. The structural and morphological properties of the obtained materials were studied by an X-ray powder
diffraction, a transmission electron microscopy techniques and infrared spectroscopy. As synthesized nano-
particles were in the range of 11–17 nm and annealed particles were in the range of 20–26 nm. The luminescence
properties in dependence of the dopant concentration and applied temperature were investigated. The 5D0→ 7F0
transition shown the abnormally strong intensity for annealed materials connected with the increase of cova-
lency character of Eu3+–O2− bond, which arise as an effect of charge compensation mechanism. The Eu3+ ions
occupied three possible crystallographic sites in these materials revealed in emission spectra: one Ca(1) site with
C3 symmetry and two Ca(2) sites with Cs symmetry arranged as cis and trans symmetry. The antibacterial
properties of Eu3+ and Sr2+ ions doped and co-doped hydroxyapatite nanopowders were also determined
against Gram-negative pathogens such as Pseudomonas aeruginosa, Klebsiella pneumoniae and Escherichia coli.
Obtained results suggest that both europium and strontium ions may implement antibacterial properties for
hydroxyapatites. In the most cases, better antibacterial effect we noticed for dopants at 5mol% ratio. However,
the effect is strongly species- and strain-dependent feature.
1. Introduction
Progressive loss of bones mineral density leads to changes in bone
architecture and higher probability of fractures. A disease called os-
teoporosis is a serious public health problem of elderly people in wes-
tern countries, which can be even worse in the future [1,2]. Un-
fortunately, human organism possesses merely a limited ability of auto-
regeneration of its major tissues and organs in the case when the tissue
integrity has been deeply damaged [3]. Because of this, materials with
stimulating capacity which can enhance the tissue regeneration are the
next generation of biomaterials [4]. One of the most important and the
best biomaterial is calcium hydroxyapatite (thereafter - HAp) which is
similar to inorganic component of bones and teeth. Because of this si-
milarity, hydroxyapatite is non-toxic for humans, bioactive and it is
broadly used in medicine [5–9]. Nevertheless, the properties of hy-
droxyapatite have been still improved through obtaining appropriate
grain size and morphology, adding some dopants such as Sr2+, Mg2+,
Zn2+, F−, CO32−, which are also naturally built into the human bone
tissue, and achieve special role in homeostasis. Due to this, these doping
agents can improve the biological response of an organism. Other ions
such as Ag+, Cu2+ and lanthanides can improve antibacterial proper-
ties of HAp or even enable bioimaging [5,10–15]. Strontium is a trace
element in human body which influences the strength, healing, and
microarchitecture of bones. Strontium ion stimulates bone formation,
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inhibits bone resorption and also improves bioactivity and biocompat-
ibility of biomaterials [16–18]. Their positive impact on osteoporosis
treatment was also observed [2,18,19]. The Sr2+ ions in the form of
orally taken strontium ranelate have been used in osteoporosis therapy,
but the bioavailability of this formulation is limited [2,20]. The in-
corporation of a small amount of Sr2+ directly into biomaterials can
additionally support osteoporosis therapy.
Biomaterials incorporated into the human body should possess an-
tibacterial properties as they are exposed to the bacterial colonization.
During the operation procedures, the human organism is also vulner-
able to the infections. Bacteria can easily develop a biofilm structure on
implants and protect themselves from environmental conditions and
human immune system. The infection developing at the site of im-
plantation can spread further and cause serious life-threatening pro-
blems [21]. Therefore, the antibacterial properties of newly designed
biomaterials are crucial for successful implantation. Nowadays, the
application of antibiotics in preoperative prophylaxis becomes limited
as the bacteria have developed multidrug resistance mechanisms. We
are facing an urgent need for new antibacterials [22]. One of the pos-
sibilities is the incorporation of different cations, having a strong an-
tibacterial effect, into the implanted biomaterials to prevent bacterial
biofilm and infection development. Amongst them, europium and
strontium depending on the concentration of ions possess documented
antibacterial effects [23,24].
In this study, there have been investigated the preparation of the
nanohydroxyapatite Ca10(PO4)6(OH)2 doped with Eu3+ and Sr2+ ions
as structurally modified biomaterial to promote bone regeneration
process (hydroxyapatite) and to enable bio-imaging (Eu3+) with addi-
tional antibacterial properties (Eu3+ and Sr2+) for theranostics appli-
cation.
2. Experimental
2.1. Synthesis of the Eu3+/Sr2+:Ca10(PO4)6(OH)2 nanopowders
The nanocrystalline powders of the Ca10(PO4)6(OH)2 co-doped with
Eu3+ and 5mol% Sr2+ ions were synthesized by precipitation method.
As starting substrates CaCO3 (99.5% metals basis Alfa Aesar), Sr(NO3)2
(min. 99.0% Alfa Aesar), NH4H2PO4 (≥99.0% Fluka), Eu2O3 (99.99%
Alfa Aesar) and NH3∙H2O (99% Avantor Poland) for pH regulation were
used. The concentration of strontium ions has been set at 5mol% and
the concentration of the optically active europium ions has been es-
tablished at 0.5, 1, 2 and 5mol% in substitution of overall molar con-
tent of divalent cations as the following process. Separately, the stoi-
chiometric amount of the CaCO3, as well as Eu2O3, was digested in an
excess of the HNO3 (suprapure Merck) to receive water-soluble nitrates.
The europium nitrates hydrates were re-crystallized three times in order
to get rid of the HNO3 excess and were dissolved in deionized water.
Afterwards, calcium nitrates and europium nitrates were mixed to-
gether. Then the appropriate amounts of NH4H2PO4 were added to
previous mixture. The pH value of the dispersion was adjusted to 10 by
ammonia. The suspensions were heated and stirred on stirring plate for
3 h. Finally, the obtained products were centrifuged, rinsed with de-
ionized water several times and dried at 70 °C for 24 h. The materials
were heat-treated at 500 °C per 3 h.
2.2. Materials characterization
The crystal phase purity of obtained materials was checked by the X-
ray powder diffraction (XRPD) technique using a PANalytical X'Pert Pro
X-ray diffractometer equipped with Ni-filtered Cu Kα1 radiation
(Kα1=1.54060 Å, V=40 kV, I=30mA). The experimental XRD pat-
terns were compared with the standard from Inorganic Crystal
Structure Database (ICSD - 180,315 [25]) to confirm the formation of
apatite structure. High-resolution transmission electron microscopy
(HRTEM) images were performed by using a Philips CM-20 SuperTwin
microscope, operating at 200 kV. Sample for HRTEM was prepared by
dispersing a small amount of specimen in methanol and putting a
droplet of the suspension on a copper microscope gird covered with
carbon. The morphology investigation and the mapping of the elements
were done by a FEI Nova NanoSEM 230 scanning electron microscope
(SEM) equipped with an energy-dispersive X-ray spectrometer (EDAX
Genesis XM4) and operating at an acceleration voltage in the range
3.0–15.0 kV and spot 2.5–3.0.
A Nicolet iS50 Fourier Transform Infrared Spectroscopy (FT-IR
Thermo Scientific) spectrometer equipped with an Automated
Beamsplitter exchange system (iS50 ABX containing DLaTGS KBr de-
tector), built-in all-reflective diamond attenuated total reflectance
module (iS50 ATR), Thermo Scientific Polaris™ and HeNe laser as an IR
radiation source were used to measure IR spectra. Polycrystalline mid-
IR spectra were collected in the 4000–400 cm−1 range in KBr pellets
and spectral resolution was set to 4 cm−1.
The excitation spectra were measured using FLS980 Fluorescence
Spectrometer (Edinburgh Instruments). A 450W xenon lamp was used
as an excitation source. The excitation of 300mm focal length mono-
chromator was in Czerny-Turner configuration. The excitation arm was
supplied with holographic grating of 1800 lines/mm grating blazed at
250 nm. As a detector, a Hamamatsu R928P photomultiplier was used.
All spectra were corrected according to the characteristics of the in-
tensity of the excitation source. The emission and luminescence kinetics
were recorded using Jobin-Yvon THR1000 monochromator equipped
with Hamamatsu R928 photomultiplier and 1200 lines/mm grating
blazed at 500 nm. A pulsed 266 nm line of YAG:Nd laser (3rd harmonic,
λexc=266 nm) was used as an excitation source. The spectral resolu-
tion was 0.1 nm. All the emission spectra were corrected to the detector
sensitivity. The decay profiles were collected using a LeCroy
WaveSurfer 400MHz oscilloscope. The luminescence kinetics were re-
corded at 617 nm according to the most intense electric dipole transi-
tion (5D0→ 7F2).
2.3. Bacterial strains
Four reference strains of Gram-negative Enterobacteriaceae, from the
American Type Culture Collection were used: Klebsiella pneumoniae
ATCC 700603, Escherichia coli ATCC 11229, Escherichia coli ATCC
25922 and Escherichia coli ATCC 35218. Bacteria were stored at −70 °C
in Trypticase Soy Broth (Becton Dickinson and Company, Cockeysville,
MD, USA) supplemented with 20% glycerol.
2.4. Determination of antibacterial activity of Eu3+/
Sr2+:Ca10(PO4)6(OH)2 nanopowders
The antimicrobial activity of the Eu3+/Sr2+:Ca10(PO4)6(OH)2 na-
nopowders was performed by the microdilution method according to
EUCAST (The European Committee on Antimicrobial Susceptibility
Testing) recommendations with previously described modifications
[9,26]. The 100 μg/mL of Ca10(PO4)6(OH)2 un-doped, doped or co-
doped with Eu3+ and Sr2+ in a saline were tested. Positive controls
(100% survival rate) consisted of bacteria inoculated in a saline,
whereas uninoculated nanopowders dilutions in saline were used as
negative controls (sterility). Each assay was repeated in triplicate at
three different times to ensure the reproducibility of results. The
number of colony forming units (CFU/mL) was determined after the
incubation at 37 °C for 20 h and compared to the positive control. The
data values were expressed as mean ± SD and significant differences
between variations (denoted p < 0.001) were found by means of the
Snedecor-Fisher test using one-way ANOVA.
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3. Results and discussion
3.1. XRD and TEM analysis
The crystal characterization of the Ca10(PO4)6(OH)2 doped with
Sr2+, doped with Eu3+ and co-doped with 5mol% Sr2+ and xEu3+ ions
nanocrystals (where x=0.5mol%, 1mol%, 2mol%, 5mol%) as-pre-
pared and annealed at 500 °C was done by means of the powder XRD
measurements (see Figs. 1 and S1). All the samples prepared by pre-
cipitation method and post-treated at 500 °C have shown only pure
crystalline phases, corresponding to the reference standard of the
hexagonal Ca10(PO4)6(OH)2 with space group P63/m characteristic for
the apatite family (ICSD-180315 [25]). Observed broadening of the
diffraction peaks is connected with the coherent size of nanocrystalline
particles. Materials were annealed also at 800 °C, but additional phase
as β-Ca3(PO4)2 was detected due to thermal decomposition caused by
Sr2+ ions [20,27].
The structural refinement was calculated by using a Maud program
version 2.68 [28,29] based on the apatite hexagonal crystal structure
with better approximation and indexing of the Crystallographic In-
formation File (CIF). The quality of structural refinement was checked
by R-values (Rw, Rwnb, Rall, Rnb, and σ) which were applied to obtain a
structural refinement with better quality and reliability. The hexagonal
phase formation as well as the successful incorporation of Sr2+ and
Eu3+ ions into the hydroxyapatite were confirmed. A good agreement
between the observed XRD pattern and the theoretical fit indicating the
success of the Rietveld refinement method is shown in Fig. S2 as a
display of small differences near to zero on the intensity scale, as illu-
strated by a line (YObs− YCalc). More details regarding Rietveld re-
finement are displayed in Tables 1 and 2. The projection of the hy-
droxyapatite co-doped with 2mol% Eu3+ and 5mol% Sr2+ unit cell
and the coordination polyhedrals of Ca2+ cations are shown in Fig. 2.
As can be seen in Table 1, it is only possible to observe a trend con-
nected with an increase of average grain size caused by the temperature
Fig. 1. X-ray powder diffraction patterns of the as-prepared (above) and annealed at 500 °C (below) Eu3+/5mol% Sr2+:Ca10(PO4)6(OH)2 nanopowders compared to
the theoretical pattern of hydroxyapatite (on the bottom of each figure) as a function of optically active ions concentration proving the crystal phase purity of
obtained compounds.
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treatment. The average grain size of as-prepared materials is very low
(11–17 nm) due to the high amount of amorphous phase present in
these materials. After applying elevated temperature in the heat-
treating process, the average grain size was growing until 20–26 nm at
the expense of amorphous phase. The a, c and V cell parameters of
obtained materials slightly decreased after thermal treatment, which is
highly expected and well-known effect. Furthermore, there is no
straightforward dopant concentration influence on the cell parameters
or cell volume.
The morphology of the pure, 5mol% Sr2+-doped and 2mol% Eu3+/
5mol% Sr2+ co-doped calcium hydroxyapatite was studied using
Transmission Electron Microscopy (TEM) and Selected Area Electron
Diffraction (SAED) techniques. As can be seen in Fig. 3, nanoparticles
are crystalline, aggregated and the shape of particles are irregular and
elongated in one direction. The morphology of nanoparticles has not
changed with the dopants substitution. The grain size has changed a
little with dopants substitution. The particles size distributions of the
studied systems were counted based on length and width diameters and
presented as histograms. The size distributions are relatively wide. The
average grain size of the pure, 5mol% Sr2+-doped and 2mol% Eu3+/
5mol% Sr2+ co-doped hydroxyapatite is about 9 nm in width and
33 nm in length, 11 nm×39 nm and 13 nm×31 nm, respectively. The
preparation of pure hydroxyapatite phase was additionally confirmed
by SAED analysis (inset).
The energy-dispersive X-ray spectrometer (EDS) as well as in-
ductively coupled plasma (ICP) were applied to confirm the content of
particular elements. The element maps were recorded by the scanning
electron microscope equipped with an energy-dispersive X-ray spec-
trometer (SEM-EDAX) in order to check the elements incorporation
frequency in the obtained material (Fig. 4). The results confirmed the
established stoichiometry of dopants as well as the regular distribution
of elements in the synthesized material.
The infrared spectra were measured for the pure, 5mol% Sr2+-
doped and 2mol% Eu3+/5mol% Sr2+ co-doped hydroxyapatite mate-
rials to investigate the functional groups present in materials and the
dopants influence onto the apatite structure (see Fig. 5). The IR spectra
consist of a typical vibrational bands of the phosphate PO43− groups at
472.0 cm−1 (the doubly degenerate v2 bending); 564.6 cm−1,
601.7 cm−1 and 632.0 cm−1 (the triply degenerate v4 vibration);
961.3 cm−1 (the v1 non-degenerate symmetric stretching);
1034.1 cm−1 and 1091.7 cm−1 (the triply degenerate v3 antisymmetric
stretching). The vibrational transition at 3571 cm−1 belongs to
stretching mode (v(OH−)) and at 633 cm−1 and to librational mode (L
(OH)) which obviously confirm the presence of the hydroxyl groups in
the structure [30,31]. The transitions at 3431.9 cm−1 and 1637.3 cm−1
correspond to the H-O-H bands of lattice water. The v3 and v4 (PO43−)
vibration bands are the IR fingerprint of hydroxyapatite structure and
their presence clearly confirms the purity of synthesized compounds
[32]. Moreover, the obtained spectra are very similar to each other and
only little differences between location of the maximum of peaks were
observed.
3.2. Excitation and emission spectra
The excitation emission spectra of the obtained samples were
measured at room temperature recording emission wavelength at
617 nm related to the most intense band of the 5D0→ 7F2 electric dipole
transition. All spectra were similar to each other without any significant
differences, therefore only the representative excitation spectrum of as-
prepared Ca10(PO4)6(OH)2:5mol% Sr2+/2mol% Eu3+ was presented
in Fig. 6. Sharp lines associated with the intraconfigurational 4f-4f
transitions characteristic for the Eu3+ ions as well as intense and
broadband related to ligand-to-metal charge transfer (CT) O2−→ Eu3+
transition located in the UV range are present in excitation spectrum.
Hence, the narrow lines observed at 299.3 nm (33,411 cm−1) were at-
tributed to the 7F0→ 5F(4,3,2,1), 3P0 transitions, at 319.6 nm
(31,289 cm−1) to 7F0→ 5H(6,5,4,7,3), at 363.5 nm (27,510 cm−1) to
7F0→ 5D4, 5L8 at 377.1 nm (26,518 cm−1) to 5L8, 7F0→G2, 5L7, 5G3, at
394.4 nm (25,355 cm−1) to 7F0→ 5L6, at 466 nm (21,459 cm−1) to
7F0→ 5D2 as well as at 527 nm (18,975 cm−1) to 7F0→ 5D1. Since the
lanthanide's f orbitals are well isolated by external shell, the f-f electron
transitions are weakly affected by the ligand field and the position of
these peaks remains almost constant regardless of the host lattice
structure. A different situation is observed in the case of the allowed CT
transition, which is strongly affected by electron-lattice coupling and
the peak position is depended on the ion's local symmetry. The CT
maximum is located at 252.3 nm (39,635 cm−1). As a matter of fact, the
substitution of divalent Ca2+ by trivalent Eu3+ cations leads to the
formation of cationic vacancies in the unit cell and the charge
Table 1
Unit cell parameters (a, c), cell volume (V), grain size as well as refine factor
(RW) for the Eu3+/5mol% Sr2+:Ca10(PO4)6(OH)2 powder as function of Eu3+
ions concentration.
Sample a (Å) c (Å) V (Å3) size (nm) Rw (%)
Single crystal [25] 9.424(4) 6.879(4) 529.09(44) – –
As prepared
Matrix 9.4218(1) 6.8744(3) 528.48(91) 12.0(1) 2.0
5mol% Sr2+ 9.4463(5) 6.8958(2) 532.89(86) 17.2(1) 2.4
0.5mol% Eu3+ 9.4550(3) 6.9021(0) 534.36(46) 12.0(3) 2.1
1mol% Eu3+ 9.4433(4) 6.8899(1) 532.10(27) 11.0(2) 3.1
2mol% Eu3+ 9.4554(3) 6.9034(3) 534.51(28) 17.0(0) 2.2
5mol% Eu3+ 9.4486(8) 6.8979(8) 533.32(86) 12.0(3) 2.5
500 °C
0.5mol% Eu3+ 9.4197(7) 6.8863(3) 529.17(47) 25.0(2) 2.5
1mol% Eu3+ 9.4392(4) 6.8955(2) 532.07(36) 22.0(2) 3.1
2mol% Eu3+ 9.4059(7) 6.8788(5) 527.05(22) 25.1(0) 2.8
5mol% Eu3+ 9.4375(9) 6.8981(2) 532.08(81) 20.0(1) 3.1
Table 2
Atomic parameters of the Eu0.02Sr0.05Ca9.93(PO4)6(OH)2.
Sample Ca10(PO4)6(OH)2: 2 mol% Eu3+/5mol%
Sr2+; Z= 1
Space group Hexagonal P63/m (No. 176)









Ca|Sr|Eu – Ca|Sr|Eu 4.1983(2) Å
Ca|Sr|Eu – O 2.2106(1) Å
Ca|Sr|Eu – P 3.2973(3) Å
P – O 1.4961(1) Å
Ca|Sr|Eu – O – Eu|Sr|Ca 124.161(1)°
Atom Wyckoff positions x y z Biso Occ. (< 1)
O1 6 h 0.3469 0.4750 0.25 0.0146906
O2 6 h 0.5846 0.4595 0.25 0.0272043
O3 12 i 0.3348 0.2414 0.0582 0.0909211
P1 6 h 0.4025 0.3477 0.25 0.0225895
Ca1 4 f 0.3324 0.6667 0.0074 0.0971982 0.9673
Ca2 6 h 0.2466 0.9822 0.25 0.0817034 0.9524
O4 4 e 0 0 0.1839 0.0713975 0.5
H1 4 e 0 0 0.0858 0.0352776 0.5
Sr1 4 f 0.3337 0.6664 0.0121 0.0662567 0.0277
Sr2 6 h 0.2576 0.9798 0.25 0.0978285 0.0326
Eu1 4 f 0.3334 0.6667 0.0075 0.0837738 0.0050
Eu2 6 h 0.2418 0.9718 0.25 0.0748735 0.0110
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compensation is required. Two mechanisms are well known and de-
scribed previously in [8,20,33].
The emission spectra of as-prepared and annealed at 500 °C 5mol%
Sr2+/x mol% Eu3+:Ca10(PO4)6(OH)2 (where x−0.5−5mol%) mate-
rials were collected in the spectral range from 400 nm to 750 nm upon
pulsed 266 nm excitation at 300 K as a function of optically active ions
concentration (see Fig. 7). All of the spectra were normalized to the
5D0→ 7F1 magnetic dipole transition. In general terms, the spectro-
scopic attitude of Eu3+ ions allows to get essential information about
the symmetry of their immediate environment, the number of their
crystallographic positions and therefore, potential sites of substitution,
structural changes taking place in the matrix influenced by external
factors [20]. Emission spectra of the trivalent europium ions consist of
characteristic bands in the visible region of the electromagnetic radia-
tion assign to the specific electron transitions occurring in the 4f-4f shell
of Eu3+ ions. In the analysis of the spectroscopic properties of Eu3+
ions, the 5D0→ 7F0,1,2 transitions are the most important, particularly in
correlation with structural properties [8,34].
In the case of as-prepared materials as well as annealed at 500 °C,
the 5D0→ 7F0 transition is split into three components located at
573.8 nm (17,428 cm−1), 577.3 nm (17,322 cm−1) and 579.2 nm
(17,265 cm−1). The Eu3+ ions are located at least into three different
sites in this crystal structure. In hydroxyapatite lattice, there are two
different kinds of crystallographic sites of Ca2+ ions: four at the Ca(1)
site with C3 symmetry, 4f position which lies on the ternary axes and six
at the Ca(2) site with Cs symmetry, 6h position [35,36]. Additionally,
cis and trans symmetry of the Cs crystallographic site related to ar-
rangements of Eu3+ ions is well-known in the literature on apatite
structures [27]. Furthermore, there is a charge incompatibility between
Ca2+ and Eu3+ ions and ionic radii incompatibility (Ca2+
(CN9)=1.18 Å, Eu3+ (CN9)=1.12 Å, Ca2+ (CN7)= 1.06 Å, Eu3+
(CN7)=1.01 Å) [37], which can lead to some variety of structural
defects connected with the requirement of charge balance. Moreover,
the Eu3+ polyhedral became more distorted after applying elevated
temperature (see R value in Table 3). The substitution of divalent Ca2+
by trivalent Eu3+ cations leads to the formation of cationic vacancies in
the lattice with the charge compensation effect described by Eq. (2).
However, the first mechanism is much more likely in case of apatite and
it is possible only for Ca(2) crystallographic site. The OH− group is
substituted by O2− camming from atmospheric oxygen during
annealing process.+ ++ +Ca (2) OH Eu O ,2 3 2 (1)
++ + V3Ca (1) 2Eu .2 3 Ca(1) (2)
The strontium substitution into calcium sites is also significant and
leads to a change in the Eu3+ ions surrounding and consequently, to the
appearance of additional lines of 0-0 transition. It is clearly visible that
there is a difference between the intensity of particular components as
well as the ratio between them. The emission of the Eu3+ ions from Ca
(1) crystallographic site is the most intense compared with the Eu3+
emission from Ca(2) sites for as-synthesized materials. Initially, the
Eu3+ ions preferentially substituted into Ca(1) position, which is well-
known for as-synthesized apatite. The thermal diffusion of Eu3+ ions
occurred from Ca(1) to Ca(2) sites after annealing process [27,38]. In
annealed materials, the 0-0 transitions from Ca(2) sites are the most
intense. It is in agreement with the charge compensation model, since
the first mechanism (1) is much more probable. Moreover, the in-
tensities of 0-0 transitions for materials annealed at 500 °C are stronger
than for as-prepared materials. The abnormal high intensity of the
5D0→ 7F0 transition can be caused by an increase of covalent character
of the Eu3+–O2− bonding formed between the Eu3+ in Ca(2) position
and O2− ions created during charge compensation mechanisms to
maintain the charge neutrality. The emission intensity from Eu(1) site
could remain the same. Due to arising of the covalency of Eu3+–O2−
bond in this material, the symmetry of the Ca(2) crystallographic site
distorted from CS to pseudo C∞V symmetry. The 5D0→ 7F0 transition is
allowed and the 5D0→ 7F2 transition is forbidden for this symmetry,
what is manifesting in the relatively strong intensity of the 5D0→ 7F0
transition [39].
The maximum of the 5D0→ 7F1 transition is located at 590.5 nm
(16,935 cm−1). The band is split into five overlapping lines for as-
prepared materials and even six lines for materials annealed at 500 °C.
Depending on local symmetry of the Eu3+ ions, the 7F1 multiplet could
be split into three non-degenerate Stark components for each crystal-
lographic with the low symmetry. However, at least three different sites
in this matrix are occupied by Eu3+ ions, which is well-known in the
literature. The most intense emission was observed for the hy-
persensitive 5D0→ 7F2 transition in both cases. The barycentre of the
5D0→ 7F2 transition is located at 616.5 nm (16,221 cm−1) and is split
Fig. 2. The projection of the 2mol% Eu3+/5mol% Sr2+:Ca10(PO4)6(OH)2 unit cell and the coordination polyhedrals of Ca2+ cations.
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into three overlapping lines in the case of as-prepared materials and
into even six lines in the case of annealed at 500 °C materials. The
maximum of the 5D0→ 7F3 transition is located at 652.4 nm
(15,328 cm−1) and the 5D0→ 7F4 band is around 701.1 nm
(14,263 cm−1). The most intense emission was observed in the case of
the hypersensitive 5D0→ 7F2 transition.
As a matter of fact, the intensity of the 5D0→ 7F2 electric dipole
transition is very sensitive to variations in the local surrounding of
Eu3+ ions in the host lattice, whereas the intensity of the 5D0→ 7F1
magnetic dipole transition is nearly independent of the crystal field
influences. If the Eu3+ ion occupies a centrosymmetric site, the only
permitted transition is the magnetic one. In opposite case, the electric
dipole transition becomes dominant. The ratio of the relative emission











In compliance with this factor, the ratio of the integral intensities of
these transitions is needed to evaluate the asymmetry of the co-
ordination polyhedron of Eu3+ ions and the variations in the local point
symmetry. In the sequel, the higher the ratio between these transitions
is, the less centrosymmetric is the local environment around Eu3+ ions.
An impact of the annealing temperature and host lattice on the R-value
is presented in Table 3. The R parameter increases with an increase of
the annealing temperature, therefore the Eu3+ local environment be-
came more distorted after post-heat treatment. Except that, no re-
lationship between an increase of dopant concentration, neither in the
Fig. 3. The particle size distribution and the representative TEM images of the pure (upper), 5 mol% Sr2+-doped (middle) and 2mol% Eu3+/5mol% Sr2+ co-doped
Ca10(PO4)6(OH)2 (bottom) as well as SAED image (inset).
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case of as-prepared materials nor heat-treated, was observed. The R-
values behave incalculably in those cases.
The simplified Judd–Ofelt theory was applied to state the intensity
parameters Ω2 and Ω4. The outcomes of this approach are listed in
Table 3. It is worth noting that the value of the Ω2 parameter slightly
changes with an increase of the Eu3+ ions concentration, but it is im-
possible to find any tendency. However, there is a possibility to note
that the value of Ω2 parameter increased in the annealed materials what
indicate an increase in the distortion of Eu3+ coordination polyhedra
and could be related to an increase of the covalence character of the
Eu3+–O2− bond. The Ω4 value provides some information about
changes in the electron density around Eu3+ cations. However, the
value of Ω4 cannot be straight connected with the Eu3+ ions symmetry
changes, but can give some information about the electron density
variations of the O2− anions surrounding influencing on the position of
the CT band.
3.3. Decay times
With the aim of determining the comprehensive characteristics of
the luminescence properties, the luminescence kinetics were analyzed
for all synthesized materials. The room temperature decay times cor-
responding to the 5D0→ 7F2 transition were measured and monitored at
the wavelength of 618 nm. The samples were excited by pulse radiation
of 266 nm and the luminescence kinetics curves are shown in Fig. 8. The
decay profiles are not single-exponential in all cases and the physical
meaning of multi-exponential fitting is complicated to explain, hence
the lifetime values were calculated from the effective emission decay
times by using the following equation:


















where I(t) is the luminescence intensity at time t corrected for the
Fig. 4. SEM-EDS element maps and EDS spectrum of the 2mol% Eu3+/5mol% Sr2+:Ca10(PO4)6(OH)2 prepared by precipitation synthesis.
Fig. 5. IR spectra of the pure, 5mol% Sr2+-doped and 2mol% Eu3+/5mol%
Sr2+ co-doped Ca10(PO4)6(OH)2 with the vibrations assigned.
Fig. 6. Representative excitation emission spectra of the as-prepared 2mol%
Eu3+/5mol% Sr2+:Ca10(PO4)6(OH)2 with the Eu3+ transitions assigned.
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background and the integrals are calculated over the range of
0 < t < tmax, where tmax≫ τm.
The decay profiles, as well as the lifetime values, are similar to each
other and only little changes were observed. The decay curves of as-
prepared materials are more non-exponential and the value of decay
times are shorter than for heat-treated materials, what could be con-
nected with higher grain size for annealed materials and consequently,
lower volume to surface ratio. Generally, the lifetime values decrease
with increase of the Eu3+ concentration in both cases as-prepared and
heat-treated materials.
3.4. Antibacterial properties of Eu3+/Sr2+: Ca10(PO4)6(OH)2
nanopowders
Despite the common practice of preoperative antimicrobial pro-
phylaxis with antibiotics and a high level of attentiveness of aseptic
condition in operating rooms, the infections after medical procedures
are still about 30% of cases. Therefore, the antibacterial activity of
implants should be considered at the stage of designing new bioactive
materials. Implantation of bones with modified hydroxyapatites with
improved biocompatibility and antibacterial effect can influence the
healing process and the patient comfort during the treatment
Fig. 7. Emission spectra of the as-prepared (above) and annealed at 500 °C (below) Eu3+/5mol% Sr2+:Ca10(PO4)6(OH)2 as a function of optically active ions
concentration with the Eu3+ transitions assigned.
Table 3
Decay rates of radiative (Arad), non-radiative (Anrad) and total (Atot) processes of 5D0→ 7FJ transitions, luminescence lifetimes (τ), intensity parameters (Ω2, Ω4),
quantum efficiency (η) and asymmetry ratio (R) of the as-prepared and annealed materials.
Sample Arad (s−1) Anrad (s−1) Atot (s−1) T (ms) Ω2 (10−20 cm2) Ω4 (10−20 cm2) η (%) R
As-prepared
0.5mol% Eu3+ 249.34 383.57 632.91 1.58 5.6101 4.6951 39.40 3.988
1mol% Eu3+ 268.10 349.18 617.28 1.62 6.3085 4.6823 43.43 4.485
2mol% Eu3+ 195.19 534.74 729.93 1.37 3.9704 3.9444 26.74 2.823
5mol% Eu3+ 219.21 635.49 854.70 1.17 4.5540 4.5775 25.65 3.238
500 °C
0.5mol% Eu3+ 311.57 162.37 473.94 2.11 7.7557 5.0110 65.74 5.514
1mol% Eu3+ 307.19 183.01 490.20 2.04 7.8770 4.4197 62.67 5.600
2mol% Eu3+ 276.55 275.94 552.49 1.81 6.7177 4.4788 50.05 4.776
5mol% Eu3+ 283.02 291.69 574.71 1.74 6.8505 4.7009 49.25 4.870
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procedure. Recently Tite et al. analyzed different cationic substitutions
in hydroxyapatites that have been reported in literature up to date.
Amongst plethora of different cations, europium and strontium were
reported to possess antibacterial effect depending on tested con-
centrations and mol% ratio of dopant in the biomaterial [23].
In presented study, six different materials were chosen to demon-
strate their antimicrobial potential: Ca10(PO4)6(OH)2 doped with Eu3+
at 2 or 5mol% ratio (2mol% Eu3+ and 5mol% Eu3+),
Ca10(PO4)6(OH)2 doped with Sr2+ at 2 or 5mol% ratio (2mol% Sr2+
and 5mol% Sr2+) and Ca10(PO4)6(OH)2 co-doped with Eu3+ and Sr2+
at 2 or 5mol% ratio (2mol% Eu3+ and 2mol% Sr2+ as well as 5mol%
Eu3+ and 5mol% Sr2+), respectively. For antibacterial properties
testing, we decided to choose different amounts of dopants alone and in
doublet to check their synergistic/antagonistic effect in designed bio-
materials.
The hydroxyapatite nanopowders were first screened at a range of
concentrations (1, 10 and 100 μg/mL) and 100 μg/mL concentration
was chosen for further tests. The antimicrobial effect was presented as a
bacterial colony count (log from CFU/mL) variation in comparison to
the control untreated culture (Fig. 9).
Considering the antimicrobial activity of tested biomaterials the
differences of 0.5-log reduction or increase in the bacterial count were
observed. Nevertheless, such differences should be considered as non-
significant from a microbiological point of view. Thus we could con-
clude that europium and strontium co-doped hydroxyapatites are
neutral to tested bacteria.
Strontium as a dopant is mainly treated as an agent that improves
biocompatibility of apatites stimulating bone formation [23]. We may find
papers showing a strong antibacterial effect of strontium ranelate-loaded
poly(lactic-co-glycolic) acid microspheres assembled with Ag nanoparticles
and hydroxyapatite nanoparticles against Gram-positive pathogen Staphy-
lococcus aureus [40]. We demonstrate here that this ion has no antibacterial
effect if prepared as co-doped hydroxyapatites. Europium alone doped
nanopowders did not have antibacterial effect on E. coli which is consistent
with previous report by Iconaru et al. [41] and Wiglusz et al. [26]. Un-
fortunately, the combination of both ions (strontium and europium) had no
improved antibacterial effect compared to single ion-doped apatites. Si-
milar dual ionic substitutions with strontium and cerium in hydroxyapatite
have been already reported by Gopi et al. [42] and conversely, the authors
noticed an antibacterial effect against S. aureus and E. coli.
Fig. 8. Decay times of the as-prepared (left) and annealed at 500 °C (right) Eu3+/5mol% Sr2+:Ca10(PO4)6(OH)2 as a function of optically active ions concentration.
The dependence of decay times on the Eu3+ ions concentration as insets in each figure.
Fig. 9. Antibacterial effect of tested Ca10(PO4)6(OH)2 un-doped, doped or co-doped with Eu3+ and Sr2+ at the colloidal suspension of 100 μg/mL in saline against
Klebsiella pneumoniae ATCC 700603, Escherichia coli ATCC 11229, Escherichia coli ATCC 25922 and Escherichia coli ATCC 35218. Controls consist of bacteria in-
oculated in saline; mean ± SD, n=3.
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4. Conclusion
A precipitation method was successfully applied to synthesized
nanopowders of the hexagonal calcium hydroxyapatite co-doped with
xEu3+ (where x=0.5, 1, 2, 5 mol%) and 5mol% Sr2+. The structural
and luminescence properties were investigated in detail for as-prepared
as well as annealed at 500 °C materials. The pure hexagonal structure
and the successful incorporation of the Eu3+ ions into the apatite lattice
were confirmed by the XRD analysis. The nanometric size of synthe-
sized apatite powders was confirmed by Rietveld calculations and TEM
microscopy. In the presented materials, the Eu3+ ions occupied three
possible crystallographic sites revealed in emission spectra: one Ca(1)
site with C3 symmetry and two Ca(2) sites with Cs symmetry arranged
as cis and trans symmetry in this lattice. In the case of as-prepared
materials, the Eu3+ ions occupied mainly Ca(1), but in the case of
annealed materials, Eu3+ ions occupied mainly Ca(2) site. Moreover,
the 5D0→ 7F0 transition shown the abnormal strong intensity for an-
nealed materials connected with the increase of covalency character of
the Eu3+–O2− bond, which arises as an effect of the charge compen-
sation mechanism. A simplified Judd–Ofelt theory in connection with
the spectroscopic properties was employed and analyzed. The change in
the R parameter yield the same trend as Ω2 parameter implied an in-
crease in the distortion of the europium coordination polyhedra and the
Eu3+–O2− bond becomes more covalent. The average lifetimes of as-
prepared materials are shorter than for annealed materials what is
connected with higher grain size in the case of annealed materials and
consequently, lower volume to surface ratio. The lifetime values de-
crease with an increase of Eu3+ ions concentration in as-prepared and
annealed materials.
The hydroxyapatite nanopowders doped with Eu3+ and Sr2+ ions
can improve bone formation as well as can enable bioimaging, but do
not have antibacterial properties. Nevertheless, such preparations can
be used as a theranostic agent come up to both functions: therapy and
diagnosis.
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